Apogee Therapeutics, Inc Common Stock

Yahoo Finance • 19 days ago

Apogee Therapeutics prices upsized $350M offering at $70 a share

Apogee Therapeutics (APGE [https://seekingalpha.com/symbol/APGE]) has announced the pricing [https://seekingalpha.com/pr/20450118-apogee-therapeutics-inc-announces-pricing-of-350-million-underwritten-public-offering] of an upsized public o... Full story

Yahoo Finance • 19 days ago

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

SAN FRANCISCO and BOSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the large... Full story

Yahoo Finance • 21 days ago

Stocks Sharply Higher as President Trump Seeks to End Iran War

The S&P 500 Index ($SPX) (SPY) on Monday closed up +1.15%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +1.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.22%.  June E-mini S&P futures (ESM26) rose +1.14%, and June E-m... Full story

Yahoo Finance • 21 days ago

How Apogee, Up 20%, Plans To Take On Rival Regeneron's Eczema Drug

Apogee Therapeutics reported a "best case scenario" Monday for its potential rival to eczema drug, Dupixent. Continue Reading... Full story

Yahoo Finance • 21 days ago

How Apogee, Up Almost 20%, Plans To Take On Rival Regeneron's Eczema Drug

Apogee Therapeutics reported a "best case scenario" Monday for its potential rival to eczema drug, Dupixent. Continue Reading... Full story

Yahoo Finance • 21 days ago

Stocks making the biggest moves midday: Palantir, Flutter, United Airlines, Synopsys, Insmed & more

Check out some of the companies making the biggest midday moves: Airlines — Delta Air Lines , United Airlines , Southwest Airlines and American Airlines surged roughly 4% after President Donald Trump said the U.S. wouldn't strike key energ... Full story

Yahoo Finance • 21 days ago

Stocks Rally as President Trump Eases Iran Threats

The S&P 500 Index ($SPX) (SPY) today is up +2.10%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +2.30%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +2.19%.  June E-mini S&P futures (ESM26) are up +2.14%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 21 days ago

Stocks Rebound as Crude Oil Sinks After President Trump Eases Iran Threats

The S&P 500 Index ($SPX) (SPY) today is up +1.73%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.97%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.79%.  June E-mini S&P futures (ESM26) are up +1.47%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 21 days ago

Top Midday Stories: Trump Orders 5-Day Postponement of Strikes on Iranian Energy Sites; JPMorgan Launches $8 Billion Junk-Bond Sale for EA Buyout

All three major US stock indexes were up in late-morning trading Monday, after President Donald Trum PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 21 days ago

Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026

SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest i... Full story

Yahoo Finance • 25 days ago

Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools

Key Points VR Adviser, LLC added 1,000,000 shares of Spyre Therapeutics; estimated trade size is $25.78 million (based on quarterly average pricing). The quarter-end value of the position increased by $75.73 million, reflecting both tradi... Full story

Yahoo Finance • 26 days ago

What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down

On February 17, 2026, VR Adviser, LLC disclosed in a U.S. Securities and Exchange Commission filing that it sold 5,845,915 shares of Ocular Therapeutix(NASDAQ:OCUL), an estimated $71.01 million trade based on quarterly average pricing. VR... Full story

Yahoo Finance • 26 days ago

Block upgraded, Starbucks downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Truist upgraded Block (XYZ) to Buy fro... Full story

Yahoo Finance • 29 days ago

VR Adviser Adds Over 1 Million Savara Shares

According to a filing with the Securities and Exchange Commission dated Feb. 17, VR Adviser, LLC increased its position in Savara(NASDAQ:SVRA) by 1,059,332 shares during the fourth quarter. The fund’s Savara stake ended the quarter valued... Full story

Yahoo Finance • last month

Wedbush Raises Price Target on Apogee Therapeutics (APGE)

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 3, Wedbush increased its price target on Apogee Therapeutics Inc. (NASDAQ:APGE) from $90 to $95. The firm mainta... Full story

Yahoo Finance • last month

Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing

On February 17, 2026, Opaleye Management Inc. reported selling out its entire stake in Immunome(NASDAQ:IMNM), an estimated $37.30 million trade based on quarterly average pricing. What Happened According to its SEC filing dated February... Full story

Yahoo Finance • last month

Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing

Opaleye Management Inc. disclosed in a February 17, 2026, SEC filing that it sold 180,000 shares of Liquidia(NASDAQ:LQDA), an estimated $5.12 million trade based on quarterly average pricing. What Happened According to a SEC filing dated... Full story

Yahoo Finance • 2 months ago

Apogee Therapeutics to Participate in Upcoming March Conferences

SAN FRANCISCO and BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Tu... Full story

Yahoo Finance • 2 months ago

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million

On February 17, 2026, Perceptive Advisors disclosed a significant buy of 431,432 shares of Praxis Precision Medicines(NASDAQ:PRAX), with an estimated transaction value of $80.34 million based on quarterly average pricing, according to its... Full story

Yahoo Finance • 2 months ago

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction

On February 17, 2026, Perceptive Advisors disclosed a buy of 978,662 shares of Apogee Therapeutics(NASDAQ:APGE), with an estimated transaction value of $61.64 million based on quarterly average pricing. What happened According to a Febru... Full story